Acta Med. 2025, 68: 129-133
https://doi.org/10.14712/18059694.2026.3
Statins and Dental Implant Osseointegration – Bridging Molecular Science and Next Generation Clinical Outcomes: A Review
References
1. A, Barroso ADV, Kirikian G, et al. The Effects of Hyperlipidemia on Implant Osseointegration in the Mouse Femur. J Oral Implantol. 2015 Apr; 41(2): e7–11.
<https://doi.org/10.1563/AAID-JOI-D-13-00105>
<PubMed>
2. IR, Mundy GR. The role of statins as potential targets for bone formation. Arthritis Res. 2002; 4(4): 237.
<https://doi.org/10.1186/ar413>
<PubMed>
3. DI, Deboni MCZ, Pannuti CM, Naclério‐Homem MG, Wennerberg A. The influence of statins on osseointegration: a systematic review of animal model studies. J Oral Rehabil. 2016 Nov; 43(11): 873–82.
<https://doi.org/10.1111/joor.12438>
4. H, Meng S, Chen J, Wan Q. Effects of Hyperlipidemia on Osseo- integration of Dental Implants and Its Strategies. J Funct Biomater. 2023 Mar 30; 14(4): 194.
<https://doi.org/10.3390/jfb14040194>
<PubMed>
5. T, Matsunuma A, Kawane T, Horiuchi N. Simvastatin Promotes Osteoblast Differentiation and Mineralization in MC3T3-E1 Cells. Biochem Biophys Res Commun. 2001 Jan; 280(3): 874–7.
<https://doi.org/10.1006/bbrc.2000.4232>
6. PY, Sun JS, Tsuang YH, Chen MH, Weng PW, Lin FH. Simvastatin promotes osteoblast viability and differentiation via Ras/Smad/Erk/BMP-2 signaling pathway. Nutr Res. 2010 Mar; 30(3): 191–9.
<https://doi.org/10.1016/j.nutres.2010.03.004>
7. MM, Eifler-Zydel J, Kolmas J. Statins – Their Role in Bone Tissue Metabolism and Local Applications with Different Carriers. Int J Mol Sci. 2024 Feb 17; 25(4): 2378.
<https://doi.org/10.3390/ijms25042378>
<PubMed>
8. S, Liberale L, Mobasheri L, et al. The role of statins in the differentiation and function of bone cells. Eur J Clin Invest. 2021 July; 51(7): e13534.
<https://doi.org/10.1111/eci.13534>
9. F, Zheng Q, Wang J. Mechanisms of bone anabolism regulated by statins. Biosci Rep. 2012 Dec 1; 32(6): 511–9.
<https://doi.org/10.1042/BSR20110118>
<PubMed>
10. H, Oh B, Park-Min KH. Regulation of Osteoclast Differentiation and Activity by Lipid Metabolism. Cells. 2021 Jan 7; 10(1): 89.
<https://doi.org/10.3390/cells10010089>
<PubMed>
11. A, Den Hartigh LJ. Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Front Cardiovasc Med. 2020 Feb 25; 7: 22.
<https://doi.org/10.3389/fcvm.2020.00022>
<PubMed>
12. A, Després JP. Pathophysiology of Human Visceral Obesity: An Update. Physiol Rev. 2013 Jan; 93(1): 359–404.
<https://doi.org/10.1152/physrev.00033.2011>
13. A, Ramos-Lopez O, Riezu-Boj JI, Milagro FI, Martinez JA. Diet, Gut Microbiota, and Obesity: Links with Host Genetics and Epigenetics and Potential Applications. Adv Nutr. 2019 Jan; 10: S17–30.
<https://doi.org/10.1093/advances/nmy078>
<PubMed>
14. S, Baptiston Tanaka C, Ross D, et al. A diet high in fat and fructose adversely affects osseointegration of titanium implants in rats. Clinical & Exp Dental Res. 2020 Feb; 6(1): 107–16.
<https://doi.org/10.1002/cre2.255>
<PubMed>
15. R, Pesce G, Calasans Maia J, Moraschini V, Calasans Maia MD, Granjeiro JM. Calcium Phosphate Carrying Simvastatin Enhances Bone Regeneration: A Systematic Review. Braz Dent J. 2020 Apr; 31(2): 93–102.
<https://doi.org/10.1590/0103-6440202002971>
16. J, Zhu LP, Yang XL, Huang HL, Ye DQ. HMG-CoA reductase inhibitors (statins) and bone mineral density: A meta-analysis. Bone. 2013 May; 54(1): 151–6.
<https://doi.org/10.1016/j.bone.2013.01.044>
17. B, Cohen R, Nicolas P, Cucherat M, Perret GY. Effects of statins on bone mineral density: A meta-analysis of clinical studies. Bone. 2007 June; 40(6): 1581–7.
<https://doi.org/10.1016/j.bone.2007.02.019>
18. C, Olsen L, Kurth C, et al. Statins inhibit protein lipidation and induce the unfolded protein response in the non-sterol producing nematode Caenorhabditis elegans. Proc Natl Acad Sci USA. 2009 Oct 27; 106(43): 18285–90.
<https://doi.org/10.1073/pnas.0907117106>
<PubMed>
19. K, Shimoda S, Nawata H, et al. Pitavastatin Enhanced BMP-2 and Osteocalcin Expression by Inhibition of Rho-Associated Kinase in Human Osteoblasts. Biochem Biophys Res Commun. 2001 Sept; 287(2): 337–42.
<https://doi.org/10.1006/bbrc.2001.5597>
20. N, Mandal CC, Choudhury GG. Statin-induced Ras Activation Integrates the Phosphatidylinositol 3-Kinase Signal to Akt and MAPK for Bone Morphogenetic Protein-2 Expression in Osteoblast Differentiation. Journal of Biological Chemistry. 2007 Feb; 282(7): 4983–93.
<https://doi.org/10.1074/jbc.M606706200>
21. H, Kanatani M, Sugimoto T, Chihara K. Statins Modulate the Levels of Osteoprotegerin/Receptor Activator of NFκB Ligand mRNA in Mouse Bone-cell Cultures. Horm Metab Res. 2005 Oct; 37(10): 589–92.
<https://doi.org/10.1055/s-2005-870538>
22. JY, Lee EY, Lee EB, et al. Atorvastatin inhibits osteoclastogenesis by decreasing the expression of RANKL in the synoviocytes of rheumatoid arthritis. Arthritis Res Ther. 2012 Aug 17; 14(4): R187.
<https://doi.org/10.1186/ar4018>
<PubMed>
23. X, Zhang C, Zhao G, Yang K, Tao L. Obesity and lipid metabolism in the development of osteoporosis (Review). Int J Mol Med. 2024 May 27; 54(1): 61.
<https://doi.org/10.3892/ijmm.2024.5385>
<PubMed>
24. J, Hu W, Zou Z, et al. The role of lipid metabolism in osteoporosis: Clinical implication and cellular mechanism. Genes Dis. 2024 July; 11(4): 101122.
<https://doi.org/10.1016/j.gendis.2023.101122>
<PubMed>



